Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Hemostasis Stories

2014-04-02 15:37:00

Discovery could lead to more effective therapies to prevent heart attacks Right now, options are limited for preventing heart attacks. However, the day may come when treatments target the heart attack gene, myeloid related protein-14 (MRP-14, also known as S100A9) and defang its ability to produce heart attack-inducing blood clots, a process referred to as thrombosis. Scientists at Case Western Reserve School of Medicine and University Hospitals Case Medical Center have reached a...

2014-02-04 08:35:29

-Now Direct with Hemostasis and Critical Care Product Lines in All Major Markets Worldwide- BEDFORD, Mass., Feb. 4, 2014 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that they have successfully completed their transition to direct sales, service, support and marketing for their Hemostasis product line in Japan. A multi-faceted team of sales and technical sales representatives, field service engineers and respective managers has been deployed throughout the...

2013-08-30 08:25:17

PISCATAWAY, N.J. and SAN DIEGO, Aug. 30, 2013 /PRNewswire/ -- ITC Nexus Holding Company (ITC), a global leader in hemostasis management and Point-of-Care (POC) testing, today announced it has acquired Accumetrics, a global leader in assessing patient response to all major antiplatelet therapies. Terms of the transaction were not disclosed. ITC develops, manufactures, and markets the Hemochron(®) product line, a market-leading POC system used to measure clotting activity for patients...

2013-07-23 08:31:28

-- Augments Fully Automated Assay Menu for the Detection of Fibrinolytic Disorders -- BEDFORD, Mass., July 23, 2013 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced the release of the HemosIL FDP assay as a European CE IVD Mark product under the European Directive on in vitro Diagnostic Medical Devices. The assay will be commercialized in countries throughout Europe, Asia, and other international markets. FDP is an immunoturbidimetric assay designed for the detection...

2012-07-09 02:25:29

BEDFORD, Mass., July 9, 2012 /PRNewswire/ -- Instrumentation Laboratory (IL), today, announced the worldwide commercial launch of the ACL TOP 300 CTS Hemostasis Testing System, as the newest member of the ACL TOP Family. Ideally suited for processing 50-100 patient samples per day, the ACL TOP 300 CTS offers full Testing Process Automation for low-to-medium-volume, routine or specialty Hemostasis laboratories or as an adjunct to other installed ACL TOP systems. The ACL TOP 300 CTS...

2012-06-11 02:25:57

RESEARCH TRIANGLE PARK, N.C., June 11, 2012 /PRNewswire/ -- Grifols, a global healthcare company based in Barcelona, Spain, today announced publication of phase 1 study results demonstrating good safety and tolerability for the investigational therapy plasmin in treating patients with blood clots in the lower extremities, known as acute peripheral arterial occlusion (aPAO). These clots can block blood flow and thus result in nerve damage, limb amputation or potentially loss of life if not...

2011-03-03 13:35:00

RESEARCH TRIANGLE PARK, N.C., March 3, 2011 /PRNewswire/ -- Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by...

2011-01-27 12:47:00

ROCKVILLE, Md., Jan. 27, 2011 /PRNewswire/ -- In a study conducted jointly by the US Army Institute of Surgical Research and STB Lifesaving Technologies®, and just published in The Journal of Trauma, STB®'s FAST® (Fibrin Adhesive STat) Dressing was shown to be superior to the most effective available agents for controlling severe arterial bleeding. The study compared currently available agents with the FAST® dressing,...

2010-11-18 17:43:00

SOMERVILLE, N.J., Nov. 18, 2010 /PRNewswire/ -- Ethicon, Inc., a worldwide leader in surgical care, announced today that the company has submitted a Biologic License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the Fibrin Pad, a novel product candidate that combines Ethicon's biomaterials and plasma-derived biologics (Human Fibrinogen and Human Thrombin), to aid in stopping soft tissue bleeding during surgery. "Excessive bleeding during surgical procedures is a...

2010-10-27 10:00:00

(Ivanhoe Newswire) -- Platelets are cell fragments that circulate in the blood of mammals.  These big, regularly-shaped cells are chiefly involved in hemostasis, a central factor leading to the formation of blood clots.  If the number of platelets is too low, excessive bleeding can occur (thrombocytopenia).  However, if the number of platelets is too high, blood clots can form (thrombosis). Mortimer Poncz and colleagues, at Children's Hospital of Philadelphia, working with...